Symbols / PTPI $0.01 +0.00% Petros Pharmaceuticals, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • PNK
PTPI Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.

Stock Fundamentals
Scroll to Statements
Market Cap 338.98K Enterprise Value -4.82M Income -50.10M Sales — Book/sh 0.08 Cash/sh 0.12
Dividend Yield — Payout 0.00% Employees — IPO — P/E — Forward P/E -0.01
PEG — P/S — P/B 0.10 P/C — EV/EBITDA 2.66 EV/Sales —
Quick Ratio 2.24 Current Ratio 2.25 Debt/Eq — LT Debt/Eq — EPS (ttm) -1.79 EPS next Y -1.09
EPS Growth — Revenue Growth — Earnings 2024-11-13 ROA -36.72% ROE — ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 42.37M Shs Float 36.26M Short Float 25.07%
Short Ratio 0.17 Short Interest — 52W High 2.62 52W Low 0.00 Beta 1.66 Avg Volume 107.17K
Volume 32.30K Target Price — Recom None Prev Close $0.01 Price $0.01 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.01
Latest analyst target
3. DCF / Fair value
$-5.43
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.01
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2023-12-08 init Maxim Group — → Buy $4
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-02 WALKER WAYNE REMELL Director — 500,000 — —
2026-01-02 BERNSTEIN BRUCE T. Director — 1,875,000 — —
2026-01-02 BOCTOR FADY President — 500,000 — —
2025-02-19 WALKER WAYNE REMELL Director — 150,000 — —
2025-02-19 BERNSTEIN BRUCE T. Director — 300,000 — —
2025-02-19 BOCTOR FADY President — 450,000 — —
2025-02-19 ARNOLD MITCHELL Officer — 150,000 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
-100.00%
5.82
-2.83%
5.99
Operating Revenue
0.00
0.00
-100.00%
5.82
-2.83%
5.99
Cost Of Revenue
—
1.21
-25.66%
1.63
-28.75%
2.29
Reconciled Cost Of Revenue
—
1.10
-26.61%
1.50
-31.00%
2.17
Gross Profit
0.00
0.00
-100.00%
4.19
+13.19%
3.70
Operating Expense
4.64
+0.31%
4.63
-69.06%
14.95
-23.50%
19.55
Research And Development
—
2.62
+8.55%
2.41
+38.43%
1.74
Selling General And Administration
4.64
+0.31%
4.63
-50.04%
9.26
-24.14%
12.21
Total Expenses
4.64
+0.31%
4.63
-72.10%
16.58
-24.05%
21.84
Operating Income
-4.64
-0.31%
-4.63
+57.01%
-10.76
+32.08%
-15.85
Total Operating Income As Reported
—
-17.68
-29.83%
-13.62
+31.63%
-19.92
EBITDA
-4.64
-0.31%
-4.63
-9.85%
-4.21
+69.31%
-13.73
Normalized EBITDA
-4.53
+44.65%
-8.18
+54.37%
-17.92
-166.46%
-6.73
Reconciled Depreciation
—
2.94
-13.80%
3.42
-40.25%
5.72
EBIT
-4.64
-0.31%
-4.63
+39.34%
-7.63
+60.77%
-19.44
Total Unusual Items
-0.12
-103.26%
3.55
-74.10%
13.71
+295.84%
-7.00
Total Unusual Items Excluding Goodwill
-0.12
-103.26%
3.55
-74.10%
13.71
+295.84%
-7.00
Special Income Charges
—
-7.38
0.00
+100.00%
-7.46
Impairment Of Capital Assets
—
7.38
0.00
-100.00%
7.46
Net Income
1.91
+113.36%
-14.32
-75.41%
-8.16
+59.26%
-20.04
Pretax Income
-4.50
-538.15%
-0.71
+91.36%
-8.16
+59.26%
-20.04
Net Non Operating Interest Income Expense
0.26
-30.89%
0.37
+1885.03%
-0.02
+96.42%
-0.58
Interest Expense Non Operating
—
0.56
+4.62%
0.54
-10.05%
0.60
Net Interest Income
0.26
-30.89%
0.37
+1885.03%
-0.02
+96.42%
-0.58
Interest Expense
—
0.56
+4.62%
0.54
-10.05%
0.60
Interest Income Non Operating
0.26
-30.89%
0.37
-27.86%
0.52
+3530.48%
0.01
Interest Income
0.26
-30.89%
0.37
-27.86%
0.52
+3530.48%
0.01
Other Income Expense
-0.12
-103.26%
3.55
+35.50%
2.62
+172.58%
-3.61
Other Non Operating Income Expenses
—
—
-11.09
-427.11%
3.39
Gain On Sale Of Security
-0.12
-103.26%
3.55
-74.10%
13.71
+2880.22%
0.46
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
1.91
+113.36%
-14.32
-75.41%
-8.16
+59.26%
-20.04
Net Income From Continuing Operation Net Minority Interest
-4.50
-538.15%
-0.71
+91.36%
-8.16
+59.26%
-20.04
Net Income From Continuing And Discontinued Operation
1.91
+113.36%
-14.32
-75.41%
-8.16
+59.26%
-20.04
Net Income Continuous Operations
-4.50
-538.15%
-0.71
+91.36%
-8.16
+59.26%
-20.04
Net Income Discontinuous Operations
6.41
+147.11%
-13.61
—
—
Normalized Income
-4.38
-3.04%
-4.26
+80.55%
-21.87
-67.76%
-13.04
Net Income Common Stockholders
-43.69
-63.04%
-26.80
-93.98%
-13.81
+31.06%
-20.04
Otherunder Preferred Stock Dividend
44.63
+338.82%
10.17
+110.57%
4.83
0.00
Diluted EPS
—
-83.47
+47.42%
-158.75
+34.40%
-242.00
Basic EPS
—
-83.47
+47.42%
-158.75
+34.40%
-242.00
Basic Average Shares
—
0.32
+268.84%
0.09
+5.11%
0.08
Diluted Average Shares
—
0.32
+268.84%
0.09
+5.11%
0.08
Diluted NI Availto Com Stockholders
-43.69
-63.04%
-26.80
-93.98%
-13.81
+31.06%
-20.04
Depreciation Amortization Depletion Income Statement
—
2.83
-13.76%
3.28
-41.36%
5.60
Depreciation And Amortization In Income Statement
—
2.83
-13.76%
3.28
-41.36%
5.60
Net Income Extraordinary
6.97
0.00
—
—
Preferred Stock Dividends
0.97
-57.80%
2.31
+180.98%
0.82
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
5.16
-51.45%
10.64
-68.53%
33.80
+4.24%
32.42
Current Assets
5.16
-29.21%
7.29
-64.23%
20.39
+39.01%
14.67
Cash Cash Equivalents And Short Term Investments
5.14
+198.88%
1.72
-87.11%
13.34
+41.49%
9.43
Cash And Cash Equivalents
5.14
+198.88%
1.72
-87.11%
13.34
+41.49%
9.43
Cash Financial
—
—
13.34
+41.49%
9.43
Receivables
—
0.42
-81.31%
2.23
+5.49%
2.11
Accounts Receivable
—
0.42
-81.31%
2.23
+5.49%
2.11
Gross Accounts Receivable
—
0.58
-79.86%
2.89
+4.69%
2.76
Allowance For Doubtful Accounts Receivable
—
-0.17
+74.99%
-0.66
-2.10%
-0.65
Other Receivables
—
—
—
—
Inventory
—
1.35
-16.18%
1.61
-11.28%
1.82
Raw Materials
—
1.26
-11.62%
1.43
-9.18%
1.57
Finished Goods
—
0.09
-52.34%
0.18
-25.03%
0.24
Prepaid Assets
—
1.81
-24.53%
2.40
+366.99%
0.51
Assets Held For Sale Current
0.00
-100.00%
5.57
—
—
Other Current Assets
0.03
+2936.84%
0.00
-99.89%
0.82
+1.74%
0.80
Total Non Current Assets
0.00
-100.00%
3.34
-75.08%
13.41
-24.49%
17.75
Net PPE
—
0.14
-46.45%
0.26
-35.82%
0.40
Gross PPE
—
0.14
-46.45%
0.26
-35.82%
0.40
Properties
—
0.00
0.00
0.00
Buildings And Improvements
—
—
—
0.36
Machinery Furniture Equipment
—
0.02
-20.75%
0.03
-26.09%
0.04
Leases
—
0.11
-49.73%
0.23
-36.88%
0.36
Goodwill And Other Intangible Assets
—
3.20
-64.28%
8.97
-26.73%
12.24
Other Non Current Assets
—
3.34
-20.04%
4.18
-18.25%
5.11
Total Liabilities Net Minority Interest
2.29
-87.33%
18.10
-15.07%
21.32
+35.61%
15.72
Current Liabilities
2.29
-87.28%
18.03
+67.38%
10.77
+52.39%
7.07
Payables And Accrued Expenses
0.23
-73.80%
0.86
-86.52%
6.41
+27.82%
5.01
Payables
0.08
-89.03%
0.76
-57.28%
1.79
-8.79%
1.96
Accounts Payable
0.08
-89.03%
0.76
-55.39%
1.71
-5.16%
1.81
Other Payable
—
0.07
-2.58%
0.08
-51.17%
0.16
Current Accrued Expenses
0.14
+43.00%
0.10
-97.84%
4.62
+51.34%
3.05
Pensionand Other Post Retirement Benefit Plans Current
—
0.00
-100.00%
0.67
+55.60%
0.43
Current Debt And Capital Lease Obligation
—
7.31
+470.48%
1.28
+4.02%
1.23
Current Debt
—
7.25
+526.75%
1.16
+6.14%
1.09
Current Capital Lease Obligation
—
0.06
-50.06%
0.13
-12.17%
0.14
Current Deferred Liabilities
2.07
+8.17%
1.91
-6.74%
2.05
0.00
Current Deferred Revenue
2.07
+8.17%
1.91
-6.74%
2.05
0.00
Other Current Liabilities
0.00
-99.99%
15.25
+4042.17%
0.37
-6.74%
0.39
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
0.08
-99.29%
10.55
+21.90%
8.65
Liabilities Heldfor Sale Non Current
0.00
-100.00%
0.08
—
—
Long Term Debt And Capital Lease Obligation
—
0.08
-98.92%
7.00
-19.14%
8.65
Long Term Debt
—
—
6.86
-18.25%
8.39
Long Term Capital Lease Obligation
—
0.08
-45.35%
0.14
-47.59%
0.26
Stockholders Equity
2.87
+138.44%
-7.47
-159.84%
12.48
-25.28%
16.70
Common Stock Equity
2.87
+138.44%
-7.47
-161.86%
12.07
-27.73%
16.70
Capital Stock
0.00
+9966.67%
0.00
-99.99%
0.41
+196669.23%
0.00
Common Stock
0.00
+9966.67%
0.00
-85.91%
0.00
+43.27%
0.00
Preferred Stock
0.00
0.00
-100.00%
0.41
0.00
Share Issued
42.28
+9940.87%
0.42
+251.95%
0.12
+43.86%
0.08
Ordinary Shares Number
42.28
+9940.87%
0.42
+251.95%
0.12
+43.86%
0.08
Additional Paid In Capital
114.16
+7.96%
105.74
-4.70%
110.96
+3.29%
107.43
Retained Earnings
-111.29
+1.69%
-113.21
-14.48%
-98.89
-9.00%
-90.73
Total Equity Gross Minority Interest
2.87
+138.44%
-7.47
-159.84%
12.48
-25.28%
16.70
Total Capitalization
2.87
+138.44%
-7.47
-138.62%
19.34
-22.93%
25.09
Working Capital
2.87
+126.75%
-10.73
-211.58%
9.62
+26.58%
7.60
Invested Capital
2.87
+138.44%
-7.47
-137.18%
20.08
-23.28%
26.18
Total Debt
—
7.39
-10.76%
8.28
-16.25%
9.88
Net Debt
—
3.54
—
0.05
Capital Lease Obligations
—
0.14
-47.60%
0.26
-35.14%
0.41
Net Tangible Assets
2.87
+138.44%
-7.47
-312.86%
3.51
-21.30%
4.46
Tangible Book Value
2.87
+138.44%
-7.47
-340.94%
3.10
-30.48%
4.46
Current Notes Payable
—
7.25
+526.75%
1.16
+6.14%
1.09
Derivative Product Liabilities
—
0.00
-100.00%
3.55
0.00
Interest Payable
—
0.33
0.00
—
Preferred Stock Equity
—
—
0.41
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-6.73
-158.72%
-2.60
+65.87%
-7.63
+40.41%
-12.80
Cash Flow From Continuing Operating Activities
-4.74
-16.99%
-4.05
+46.84%
-7.63
+40.41%
-12.80
Cash From Discontinued Operating Activities
-1.99
-237.19%
1.45
—
—
Net Income From Continuing Operations
2.47
+450.73%
-0.71
+91.36%
-8.16
+59.26%
-20.04
Depreciation Amortization Depletion
—
2.94
-13.80%
3.42
-40.25%
5.72
Depreciation
—
2.94
-13.80%
3.42
-40.25%
5.72
Depreciation And Amortization
—
2.94
-13.80%
3.42
-40.25%
5.72
Other Non Cash Items
—
0.27
-97.57%
11.09
+448.83%
-3.18
Stock Based Compensation
0.30
+54.47%
0.20
-52.73%
0.42
-65.09%
1.20
Provisionand Write Offof Assets
—
-0.05
+31.77%
-0.07
-262.61%
-0.02
Asset Impairment Charge
—
7.38
+26026.71%
0.03
-99.61%
7.29
Deferred Tax
—
—
—
—
Deferred Income Tax
—
—
—
—
Operating Gains Losses
-6.86
-93.17%
-3.55
+76.28%
-14.97
-3154.13%
-0.46
Gain Loss On Investment Securities
0.12
+103.26%
-3.55
+76.28%
-14.97
-3154.13%
-0.46
Change In Working Capital
-0.66
-148.91%
-0.27
-142.66%
0.62
+118.92%
-3.30
Change In Receivables
—
1.82
+1361.79%
-0.14
-127.94%
0.52
Changes In Account Receivables
—
1.82
+1361.79%
-0.14
-127.94%
0.52
Change In Inventory
—
0.31
+12.42%
0.27
+132.76%
-0.84
Change In Prepaid Assets
-0.03
-173.61%
0.04
+103.65%
-0.97
-158.72%
1.65
Change In Payables And Accrued Expense
-0.64
-111.19%
-0.30
-118.50%
1.63
+135.84%
-4.55
Change In Accrued Expense
0.04
+106.55%
-0.65
-137.88%
1.73
+195.73%
-1.80
Change In Payable
-0.68
-293.44%
0.35
+477.63%
-0.09
+96.61%
-2.75
Change In Account Payable
-0.68
-293.44%
0.35
+477.63%
-0.09
+96.61%
-2.75
Change In Other Working Capital
—
-0.12
+28.57%
-0.16
—
Change In Other Current Liabilities
—
-0.36
-7358.46%
-0.00
+93.72%
-0.08
Investing Cash Flow
0.00
+100.00%
-0.02
0.00
—
Cash Flow From Continuing Investing Activities
—
-0.02
0.00
—
Cash From Discontinued Investing Activities
0.00
+100.00%
-0.02
—
—
Net PPE Purchase And Sale
—
-0.02
0.00
—
Purchase Of PPE
—
-0.02
0.00
—
Capital Expenditure
—
-0.02
—
—
Gain Loss On Sale Of Business
-6.97
0.00
—
—
Financing Cash Flow
8.16
+216.60%
-7.00
-160.67%
11.54
+810.43%
-1.62
Cash Flow From Continuing Financing Activities
8.16
+216.60%
-7.00
-160.67%
11.54
+810.43%
-1.62
Net Issuance Payments Of Debt
0.00
+100.00%
-0.77
+47.72%
-1.46
+9.86%
-1.62
Issuance Of Debt
—
—
—
—
Repayment Of Debt
0.00
+100.00%
-0.77
+47.72%
-1.46
+9.86%
-1.62
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
0.00
+100.00%
-0.77
+47.72%
-1.46
+9.86%
-1.62
Net Long Term Debt Issuance
0.00
+100.00%
-0.77
+47.72%
-1.46
+9.86%
-1.62
Net Common Stock Issuance
8.50
0.00
—
0.00
Repurchase Of Capital Stock
-0.34
+94.52%
-6.23
-211.88%
-2.00
0.00
Proceeds From Stock Option Exercised
—
—
—
0.00
Net Other Financing Charges
—
—
15.00
—
Changes In Cash
1.43
+114.82%
-9.63
-346.17%
3.91
+127.12%
-14.42
Beginning Cash Position
3.71
-72.18%
13.34
+41.49%
9.43
-60.47%
23.85
End Cash Position
5.14
+38.46%
3.71
-72.18%
13.34
+41.49%
9.43
Free Cash Flow
-6.73
-158.72%
-2.60
+65.87%
-7.63
+40.41%
-12.80
Interest Paid Supplemental Data
0.00
0.00
-100.00%
0.54
-10.05%
0.60
Common Stock Issuance
8.50
0.00
—
0.00
Issuance Of Capital Stock
8.50
0.00
—
0.00
Net Preferred Stock Issuance
-0.34
+94.52%
-6.23
-211.88%
-2.00
0.00
Preferred Stock Payments
-0.34
+94.52%
-6.23
-211.88%
-2.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category